KR20060129549A - 라우소니아 인트라셀룰라리스의 배양, 항―라우소니아인트라셀룰라리스 백신 및 진단 시약 - Google Patents

라우소니아 인트라셀룰라리스의 배양, 항―라우소니아인트라셀룰라리스 백신 및 진단 시약 Download PDF

Info

Publication number
KR20060129549A
KR20060129549A KR1020067024337A KR20067024337A KR20060129549A KR 20060129549 A KR20060129549 A KR 20060129549A KR 1020067024337 A KR1020067024337 A KR 1020067024337A KR 20067024337 A KR20067024337 A KR 20067024337A KR 20060129549 A KR20060129549 A KR 20060129549A
Authority
KR
South Korea
Prior art keywords
bacteria
intracellular
cells
culture
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020067024337A
Other languages
English (en)
Korean (ko)
Inventor
제프리 피 크니텔
미카엘 비이 루프
Original Assignee
베링거 인겔하임/노블 래보라토리즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27041284&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20060129549(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/465,337 external-priority patent/US5714375A/en
Application filed by 베링거 인겔하임/노블 래보라토리즈, 인코포레이티드 filed Critical 베링거 인겔하임/노블 래보라토리즈, 인코포레이티드
Publication of KR20060129549A publication Critical patent/KR20060129549A/ko
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C12N9/92—Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
KR1020067024337A 1995-06-05 1996-06-05 라우소니아 인트라셀룰라리스의 배양, 항―라우소니아인트라셀룰라리스 백신 및 진단 시약 Ceased KR20060129549A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/465,337 1995-06-05
US08/465,337 US5714375A (en) 1995-06-05 1995-06-05 Ileal symbiont intracellularis propagation in suspended host cells
US08/658,194 1996-06-04
US08/658,194 US5885823A (en) 1995-06-05 1996-06-04 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020057003259A Division KR100758614B1 (ko) 1995-06-05 1996-06-05 라우소니아 인트라셀룰라리스의 배양, 항-라우소니아 인트라셀룰라리스 백신 및 진단시약

Publications (1)

Publication Number Publication Date
KR20060129549A true KR20060129549A (ko) 2006-12-15

Family

ID=27041284

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020067024337A Ceased KR20060129549A (ko) 1995-06-05 1996-06-05 라우소니아 인트라셀룰라리스의 배양, 항―라우소니아인트라셀룰라리스 백신 및 진단 시약
KR1019970708990A Expired - Lifetime KR100513481B1 (ko) 1995-06-05 1996-06-05 라우소니아인트라셀루라리스의배양,항-라우소니아인트라셀룰라리스백신및진단시약
KR1020057003259A Expired - Lifetime KR100758614B1 (ko) 1995-06-05 1996-06-05 라우소니아 인트라셀룰라리스의 배양, 항-라우소니아 인트라셀룰라리스 백신 및 진단시약
KR1020057005243A Expired - Lifetime KR100544857B1 (ko) 1995-06-05 1996-06-05 라우소니아 인트라셀룰라리스의 배양, 항-라우소니아인트라셀룰라리스 백신 및 진단시약

Family Applications After (3)

Application Number Title Priority Date Filing Date
KR1019970708990A Expired - Lifetime KR100513481B1 (ko) 1995-06-05 1996-06-05 라우소니아인트라셀루라리스의배양,항-라우소니아인트라셀룰라리스백신및진단시약
KR1020057003259A Expired - Lifetime KR100758614B1 (ko) 1995-06-05 1996-06-05 라우소니아 인트라셀룰라리스의 배양, 항-라우소니아 인트라셀룰라리스 백신 및 진단시약
KR1020057005243A Expired - Lifetime KR100544857B1 (ko) 1995-06-05 1996-06-05 라우소니아 인트라셀룰라리스의 배양, 항-라우소니아인트라셀룰라리스 백신 및 진단시약

Country Status (23)

Country Link
US (1) US5885823A (https=)
EP (5) EP1645567B2 (https=)
JP (4) JP3765834B2 (https=)
KR (4) KR20060129549A (https=)
AT (3) ATE289069T1 (https=)
AU (1) AU717045B2 (https=)
BG (1) BG64292B1 (https=)
BR (2) BRPI9612938B8 (https=)
CA (1) CA2222643C (https=)
CZ (1) CZ295933B6 (https=)
DE (5) DE122007000102I1 (https=)
DK (3) DK1403643T3 (https=)
ES (3) ES2294620T5 (https=)
FR (1) FR07C0071I2 (https=)
HU (1) HU230199B1 (https=)
LU (1) LU91405I2 (https=)
NL (1) NL300331I2 (https=)
NZ (1) NZ319994A (https=)
PL (6) PL189287B1 (https=)
PT (3) PT843818E (https=)
RO (1) RO118885B1 (https=)
RU (2) RU2265849C2 (https=)
WO (1) WO1996039629A1 (https=)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE329031T1 (de) * 1995-11-30 2006-06-15 Agriculture Victoria Serv Pty Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
CA2372105A1 (en) * 1999-05-13 2000-11-23 Pfizer Products Inc. Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
JP2003516113A (ja) * 1999-05-13 2003-05-13 ファイザー プロダクツ インコーポレーティッド ローソニア由来の遺伝子及び関連ＦｌｇＥポリペプチド、ぺプチド及びタンパク質並びにそれらの使用
US7052697B1 (en) * 1999-05-13 2006-05-30 Agriculture Victoria Services Pty Ltd Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
US7029683B1 (en) 1999-05-13 2006-04-18 Pfizer Products, Inc. Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
JP2003501013A (ja) * 1999-05-13 2003-01-14 ファイザー プロダクツ インコーポレーティッド ローソニア由来の遺伝子及び関連ＳｏｄＣポリペプチド、ぺプチド及びタンパク質並びにそれらの使用
MXPA01011570A (es) * 1999-05-13 2003-08-20 Australian Pork Ltd Gen derivado de lawsonia y polipeptidos, peptidos y proteinas relacionadas con peptido h de membrana externa.
US6605696B1 (en) * 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
CA2423588A1 (en) * 2000-09-29 2002-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Improved vaccines for proliferative ileitis and methods of making and using the same
AUPR138100A0 (en) 2000-11-10 2000-12-07 Agriculture Victoria Services Pty Ltd Novel therapeutic compositions for treating infection by lawsonia spp
JP2004512851A (ja) * 2000-11-10 2004-04-30 アグリカルチュア　ビクトリア　サービシーズプロプライエトリー　リミティッド ラウソニア種による感染を処置する新規な治療用組成物
ES2360225T3 (es) * 2000-12-20 2011-06-02 Intervet International Bv Vacuna contra lawsonia intracellularis.
US20030087421A1 (en) * 2001-07-11 2003-05-08 Gebhart Connie J Lawsonia intracellularis
CA2501238A1 (en) * 2002-10-04 2004-04-22 Regents Of The University Of Minnesota Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
KR101131845B1 (ko) * 2003-07-25 2012-03-30 베링거잉겔하임베트메디카인코퍼레이티드 유럽 기원의 로소니아 인트라셀룰라리스, 및 이의 백신,진단제 및 사용 방법
CA2536989A1 (en) * 2003-09-12 2005-03-24 Akzo Nobel N.V. Lawsonia intracellularis subunit vaccine
KR20060112674A (ko) * 2003-12-09 2006-11-01 인터벳 인터내셔널 비.브이. 로소니아 인트라셀룰라리스 26 ｋｄ 서브유닛 백신
CA2554472A1 (en) * 2004-01-22 2005-08-04 Intervet International B.V. Lawsonia intracellularis subunit vaccines
MY146476A (en) 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
EP1609870A1 (en) * 2004-06-24 2005-12-28 Boehringer Ingelheim Vetmedica Gmbh Method of diagnosing lawsonia intracellularis
US20060021536A1 (en) * 2004-07-30 2006-02-02 Limin Song Method for creating an absorbent article exhibiting a harmonic color scheme
KR100621882B1 (ko) * 2004-09-30 2006-09-19 건국대학교 산학협력단 돼지 증식성 회장염 감염돈에서 로소니아인트라셀룰라리스 균을 분리하는 방법
AU2005308583A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Methods for cultivating Lawsonia intracellularis
US20070212373A1 (en) * 2004-12-08 2007-09-13 Akzo Nobel N.V. Lawsonia Intracellularis 26 Kd Subunit Vaccine
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) * 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
EP1968630B1 (en) 2005-12-29 2018-01-24 Boehringer Ingelheim Vetmedica, Inc. Multivalent pcv2 immunogenic compositions
MX338626B (es) 2005-12-29 2016-04-26 Boehringer Ingelheim Vetmed Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
EP2859900A1 (en) 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
JP5200223B2 (ja) * 2006-12-15 2013-06-05 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド Ｐｃｖ２抗原によるブタの処置
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
WO2009037262A2 (en) 2007-09-17 2009-03-26 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early lawsonia intracellularis infections
MX2010003879A (es) * 2007-10-12 2010-04-30 Pfizer Metodos de cultivo de lawsonia intracellularis.
WO2009088950A2 (en) * 2007-12-31 2009-07-16 Boehringer Ingelheim Vetmedica, Inc. Pcv2 orf2 virus like particle with foreign amino acid insertion
KR20100113582A (ko) * 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
US20110033495A1 (en) * 2008-02-15 2011-02-10 Boehringer Ingelheim Vetmedica, Inc. Methods and compositions for reducing the impact of enteric diseases
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
US8557254B2 (en) 2008-07-22 2013-10-15 Intervet Inc. Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel Lawsonia intracellularis serotype and hybridomas for producing the said antibodies
US8142760B2 (en) * 2008-09-05 2012-03-27 Nathan Len Winkelman Vaccination for Lawsonia intracellularis
WO2011006880A1 (en) * 2009-07-14 2011-01-20 Intervet International B.V. Lawsonia intracellularis propagation
AR078253A1 (es) * 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
US8530223B2 (en) * 2009-11-09 2013-09-10 Intervet International B.V. Method to grow Lawsonia intracellularis bacteria in persistently infected McCoy cells
PT2938747T (pt) 2012-12-28 2019-08-01 Boehringer Ingelheim Vetmedica Gmbh Método de preparação de uma vacina de micoplasma
EP3049106A1 (en) 2013-09-25 2016-08-03 Zoetis Services LLC Pcv2b divergent vaccine composition and methods of use
US9505808B2 (en) 2013-10-02 2016-11-29 Boehringer Ingelheim Vetmedica, Inc. PCV2 ORF2 protein variant and virus like particles composed thereof
US10751405B2 (en) 2015-02-04 2020-08-25 Intervet Inc. Vaccine for use against subclinical Lawsonia infection in a pig
ES2798282T3 (es) 2015-02-04 2020-12-10 Intervet Int Bv Una vacuna para usar contra la infección asintomática por Lawsonia en un cerdo
KR20180062468A (ko) * 2016-11-18 2018-06-11 녹십자수의약품(주) 신규한 로소니아 인트라셀룰라리스 균주 및 이의 용도
BR112020017520A2 (pt) 2018-02-28 2020-12-22 Boehringer Ingelheim Vetmedica Gmbh Método para redução de escatol e/ou indol em animais
JP7657287B2 (ja) 2020-07-24 2025-04-04 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 組合せブタワクチン
MX2024005116A (es) 2021-11-01 2024-05-16 Boehringer Ingelheim Vetmedica Gmbh Composiciones de gel inmunogenas.
WO2024068637A1 (en) * 2022-09-27 2024-04-04 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria
WO2024260953A1 (en) * 2023-06-23 2024-12-26 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria
CN119185351B (zh) * 2024-09-25 2025-09-16 武汉轻工大学 Li0004蛋白靶点在制备抑制劳森菌感染细胞增殖的药物中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132597A (en) * 1976-06-09 1979-01-02 Ab Medipharm Method for cultivation of bacteria
US4237218A (en) * 1979-02-09 1980-12-02 Bio-Rad Laboratories, Inc. Micro-carrier cell culture
JPS5991879A (ja) * 1982-11-16 1984-05-26 Hideaki Yamada シユ−ドモナス属細菌の培養法
DK594084A (da) * 1984-12-12 1986-06-13 Novo Industri As Fremgangsmaade til stabilisering af extra-chromosomale elementer i bakterier under dyrkning
JPH0644865B2 (ja) * 1985-10-29 1994-06-15 三菱瓦斯化学株式会社 カンピロバクタ−属細菌の培養方法
US5338670A (en) * 1986-07-28 1994-08-16 The United States Of America As Represented By The Department Of Health And Human Services Production of bordetella pertussis toxin with a low concentration of iron
IT1227657B (it) * 1988-12-01 1991-04-23 Mini Ricerca Scient Tecnolog Antibiotici ab-021 e processo per la loro produzione
JPH0822221B2 (ja) * 1988-12-28 1996-03-06 日東化学工業株式会社 シュードモナス属細菌の培養法
JPH02308754A (ja) * 1989-05-24 1990-12-21 Yakult Honsha Co Ltd 乳発酵食品の製造法
US5296221A (en) * 1990-01-31 1994-03-22 Sani-Ei Sucrochemical Co., Ltd. Lactobacillus johnsonii ferm bp-2680 lactic acid bacteria preparations using the same and a process of manufacturing the preparations
CA2094515C (en) * 1990-11-01 1998-09-01 Theodore T. Kramer Bacterial attenuation method and vaccine
SU1768637A1 (en) * 1990-12-04 1992-10-15 Inst Virusologii Im D I Ivanov Strain of human immunodeficient virus 1-type for preparation of diagnostic preparation
EP0669971B1 (en) * 1991-11-15 2003-03-19 Pfizer Inc. Method of producing gram-negative bacterial vaccines
DE4208785A1 (de) * 1992-03-19 1993-09-23 Degussa Verfahren zum auffinden von insertionselementen (is-elemente) oder transposonen
US5610059A (en) * 1992-11-09 1997-03-11 University Of Arizona Etiological agent for porcine enteritis

Also Published As

Publication number Publication date
FR07C0071I2 (fr) 2010-12-31
JP4263212B2 (ja) 2009-05-13
DK1645567T4 (en) 2016-04-11
EP0843818A1 (en) 1998-05-27
PL187849B1 (pl) 2004-10-29
ATE441863T1 (de) 2009-09-15
KR100513481B1 (ko) 2006-01-27
JP5078740B2 (ja) 2012-11-21
AU6262796A (en) 1996-12-24
EP1403643A1 (en) 2004-03-31
EP0843818A4 (en) 2002-02-06
ATE289069T1 (de) 2005-02-15
JP2008266340A (ja) 2008-11-06
PL189250B1 (pl) 2005-07-29
PL325872A1 (en) 1998-08-17
DE69638016D1 (de) 2009-10-15
KR20050046741A (ko) 2005-05-18
EP1403643B2 (en) 2018-10-03
BG102130A (bg) 1998-09-30
BRPI9612938B8 (pt) 2017-09-12
NZ319994A (en) 2000-01-28
EP1645567B1 (en) 2007-09-12
WO1996039629A1 (en) 1996-12-12
CA2222643A1 (en) 1996-12-12
JPH11507225A (ja) 1999-06-29
CZ389997A3 (cs) 1998-07-15
KR20050048651A (ko) 2005-05-24
RU2005114739A (ru) 2006-11-20
EP1645567A1 (en) 2006-04-12
HK1010911A1 (en) 1999-07-02
EP2199795A3 (en) 2010-11-03
DE69637251T3 (de) 2016-06-02
ES2294620T3 (es) 2008-04-01
CA2222643C (en) 2013-08-13
DE69634334D1 (de) 2005-03-17
ATE373015T1 (de) 2007-09-15
BR9608338A (pt) 1999-01-05
RU2265849C2 (ru) 2005-12-10
PT1645567E (pt) 2007-11-19
PL189286B1 (pl) 2005-07-29
NL300331I2 (nl) 2008-07-01
EP1655607B1 (en) 2015-05-13
EP1403643B1 (en) 2009-09-02
ES2294620T5 (es) 2016-03-23
RO118885B1 (ro) 2003-12-30
DE69637251D1 (de) 2007-10-25
NL300331I1 (nl) 2008-03-03
ES2332587T3 (es) 2010-02-09
KR100544857B1 (ko) 2006-01-24
DE69634334T2 (de) 2006-04-13
LU91405I2 (fr) 2008-02-21
DE122007000102I1 (de) 2008-04-17
DE69637251T2 (de) 2008-06-12
EP1645567B2 (en) 2016-01-06
KR19990022509A (ko) 1999-03-25
PL189287B1 (pl) 2005-07-29
ES2173055T3 (es) 2005-07-01
FR07C0071I1 (https=) 2008-01-02
EP0843818B1 (en) 2005-02-09
JP2006061165A (ja) 2006-03-09
JP2007151554A (ja) 2007-06-21
JP3765834B2 (ja) 2006-04-12
EP2199795A2 (en) 2010-06-23
HUP9900884A2 (hu) 1999-07-28
EP1655607A1 (en) 2006-05-10
PL187850B1 (pl) 2004-10-29
HUP9900884A3 (en) 2001-01-29
EP0843818B2 (en) 2018-12-19
PT1403643E (pt) 2009-10-08
RU2305707C2 (ru) 2007-09-10
PT843818E (pt) 2005-04-29
DK1403643T3 (da) 2010-01-04
ES2173055T1 (es) 2002-10-16
KR100758614B1 (ko) 2007-09-13
BRPI9612938B1 (pt) 2010-07-27
BR9608338B1 (pt) 2009-05-05
CZ295933B6 (cs) 2005-12-14
PL189187B1 (pl) 2005-07-29
AU717045B2 (en) 2000-03-16
US5885823A (en) 1999-03-23
JP3920300B2 (ja) 2007-05-30
DK0843818T3 (da) 2005-05-09
HU230199B1 (hu) 2015-10-28
EP2199795B1 (en) 2016-03-30
BG64292B1 (bg) 2004-08-31
MX9709464A (es) 1998-06-30
DE843818T1 (de) 2002-11-28
DK1645567T3 (da) 2007-11-26

Similar Documents

Publication Publication Date Title
KR100758614B1 (ko) 라우소니아 인트라셀룰라리스의 배양, 항-라우소니아 인트라셀룰라리스 백신 및 진단시약
US20080112980A1 (en) Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
CN1519311B (zh) 胞内劳森氏菌培养、抗该菌的疫苗和诊断试剂
MXPA97009464A (en) Culture of lawsonia intracellularis, vaccines against lawsonia intracellulares and agents of diagnost
HK1067662B (en) Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
HK1081594B (en) Lawsonia intracellularis cultivation in mccoy cell
HK1010911B (en) Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20061120

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20070126

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20080623

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20070126

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20080924

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20080623

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20100628

Appeal identifier: 2008101009673

Request date: 20080924

AMND Amendment
PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20081024

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20080924

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20080128

Patent event code: PB09011R02I

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20081128

Patent event code: PE09021S01D

B601 Maintenance of original decision after re-examination before a trial
PB0601 Maintenance of original decision after re-examination before a trial
J301 Trial decision

Free format text: TRIAL NUMBER: 2008101009673; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20080924

Effective date: 20100628

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20080924

Effective date: 20100628

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20100628

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20080924

Decision date: 20100628

Appeal identifier: 2008101009673

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20100730

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

J2X1 Appeal (before the patent court)

Free format text: TRIAL NUMBER: 2010201005581; APPEAL AGAINST DECISION TO DECLINE REFUSAL

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

PJ2001 Appeal

Patent event date: 20100628

Comment text: Trial Decision on Objection to Decision on Refusal

Patent event code: PJ20011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20110617

Appeal identifier: 2010201005581

Request date: 20100802

J302 Written judgement (patent court)

Free format text: TRIAL NUMBER: 2010201005581; JUDGMENT (PATENT COURT) FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20100802

Effective date: 20110617

Free format text: JUDGMENT (PATENT COURT) FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20100802

Effective date: 20110617

PJ1302 Judgment (patent court)

Patent event date: 20110620

Comment text: Written Judgment (Patent Court)

Patent event code: PJ13021S01D

Request date: 20100802

Decision date: 20110617

Appeal identifier: 2010201005581

Appeal kind category: Appeal against decision to decline refusal